Synaptic vesicle fusion (exocytosis) is a precisely regulated process that entails the formation of 17 SNARE complexes between the vesicle protein synaptobrevin 2 (VAMP2) and the plasma membrane 18
The release of neurotransmitter by synaptic vesicle fusion is an extremely rapid process, which 2 follows neuronal stimulation with high precision. Its control relies on several proteins that serve to 3 dock synaptic vesicles at the fusion site (active zone) or to sense increases in the intracellular Ca 2+ 4 concentration, which marks the physiological trigger for fusion. 1 The act of fusion itself, however, 5 relies almost exclusively on three soluble N-ethylmaleimide sensitive factor attachment receptor 6 (SNARE) proteins: Synaptobrevin 2 (VAMP2), located on synaptic vesicles, and the plasma 7 membrane proteins Syntaxin 1A and SNAP-25. 2 They mediate exocytosis by forming a heteromeric 8 helical bundle that brings the two membranes together and forces their fusion. 3 All of these molecules 9 are highly abundant in synaptic terminals, with ~70 VAMP2 molecules on average found on the 10 synaptic vesicle 4,5 and with thousands of SNAP-25 and Syntaxin 1A molecules on the synapse 11 surface. 5 12
While the localization of synaptobrevin 2 on the vesicle surface is fairly clear, the location of 13 SNAP-25 and Syntaxin 1A is less understood. Investigation by super-resolution imaging revealed that 14 both SNAP-25 and Syntaxin 1A are enriched at synapses. 5 At the same time, analyses by immuno-15 electron microscopy have provided less clear-cut results, with the proteins present both in synapses 16 and in other axonal regions. 6 In addition, both SNAP-25 and Syntaxin 1A have been studied in 17 neuroendocrine PC12 cells, where their distributions have been thoroughly characterized. In brief, 18 both molecules form clusters. 7-10 More specifically, Syntaxin 1A forms dense clusters of ~75 19 molecules grouped in a roughly circular area with a diameter of 50-60 nm 8 while SNAP-25 appears to 20 form larger and more loose clusters of ~130 nm in diameter. 9 Cluster formation does seem to take 21 place also at synapses, with the clusters possibly containing both SNAP-25 and Syntaxin 1A 22 molecules, at least to some extent. 11 The localization of these proteins has also been investigated by 23 live-cell imaging, using GFP-tagged proteins. While these GFP-tagged molecules showed clusters in 24 PC12 membranes, 10 a GFP-tagged Syntaxin 1A chimera revealed an overall homogenous labeling 25 pattern on the plasma membrane of cultured neurons. 12 26 At the same time, a caveat of most super-resolution studies on membrane proteins has been the 27 application of conventional antibodies for target detection. It was repeatedly demonstrated that the 28 Syntaxin 1A outside the synapses, which were poorly revealed by the antibodies. Furthermore, the 23 extra-synaptic Syntaxin 1A molecules, but not the SNAP-25 molecules, were recruited to the synaptic 24 boutons center upon strong neuronal stimulation. In addition, two-color investigations using super-25 resolution microscopy also showed that the SNAP-25 and Syntaxin 1A are better correlated than 26 previous antibody-based measurements have suggested both within and outside synapses. Overall, 27 these findings suggest that small, monovalent probes such as nanobodies are able to detect not only 1 quantitative, but also qualitative differences in molecular distribution, when compared to antibodies. To obtain nanobodies for SNAP-25 and Syntaxin 1A ( Figure 1A) , we first immunized an 6 alpaca (Vicugna pacos) with rat Syntaxin 1A lacking its C-terminal transmembrane domain (residues 7 1-262), and with full-length rat SNAP-25. The cysteine residues of the latter were mutated to serines, 8 to facilitate expression in E. coli ( Figure 1B ). After two panning rounds of phage display 24 9 (Supplementary Figure 1A) , 22 and 11 ELISA-positive families of nanobodies were identified for 10 SNAP-25 and Syntaxin 1A, respectively. The most abundant member present in each of the families 11 was produced in E. coli in a small scale and their specificity was further evaluated by dot-blot assays. 12
Such candidates were then used to immunostain fibroblast cells transiently expressing SNAP-25 or 13
Syntaxin 1A fused to EGFP (Supplementary Figure 1B) . The nanobodies showing specific signals and 14 minimal background in the immunostaining were subsequently sub-cloned into a bacterial expression 15 vector that includes a cysteine at their C-terminus for direct conjugation to a fluorophore. 25 
17
The nanobody candidates termed S25-Nb10 and Stx1A-Nb6 performed best for the 18 immunostainings of SNAP-25 and Syntaxin 1A, respectively, and were used for all further 19 experiments. As a first step, dissociation constants (KD) were determined by microscale 20 thermophoresis. We found that S25-Nb10 binds to recombinant SNAP-25 with a KD of 15.5±3.3 nM, 21 and that Stx1A-Nb6 binds to recombinant Syntaxin 1A with a KD of 5.0±1.2 nM in vitro at room 22 temperature (Supplementary Figure 2 ). Monovalent probes with dissociation constants in this range 23 are considered high affinity binders. 26 Schematic view of antigens used for the immunization and their wild-type forms. Important functional domains 8 are marked in gray (TM=trans-membrane domain) and the amino acids positions are denoted below. For 9 immunization (injected), all four cysteine residues of SNAP-25 were mutated to serines. For injection of 10 Syntaxin 1A, only the cytosolic portion of the molecule was used to facilitate it expression in E. coli.
12
To identify the epitopes of the nanobodies, we tested different truncated constructs of both 13 SNAP-25 and Syntaxin1A for nanobody binding. Equimolar amounts of these constructs were spotted 14 on a nitrocellulose membrane and were detected by the respective fluorescently labeled nanobodies in 15 dot-blot assays ( Figure 2 ). The blots suggested that S25-Nb10 binds within the first 86 N-terminal 16 residues of SNAP-25, which is one of the two alpha helixes that SNAP-25 contributes to a SNARE 17 complex. 27 Stx1A-Nb6 binds within the first 112 residues of the N-terminal portion of Syntaxin 1A, 18
which are part of the regulatory Habc domain of Syntaxin 1A. 28 19
After determining the binding strength and epitope localization of the nanobodies, we 1 proceeded to evaluate their specificity within their target families. Several homolog proteins are 2 known for both SNAP-25 and Syntaxin 1A (Supplementary Figure 3A , 3B). We therefore tested the 3 binding of the nanobodies to the closest homologs by dot-blot assays. Both nanobodies displayed high 4 specificity, with minimal cross-reactivity to any of the tested homologs (Supplementary Figure 3C 
14
We next focused on characterizing the nanobody performance in cellular immunostainings. As 15 a first attempt, we transiently expressed wildtype rat SNAP-25 or Syntaxin 1A, fused to EGFP, in a 16 fibroblast cell line (COS-7 cells), where these proteins are not expressed endogenously. SNAP- EGFP was distributed as expected, on the membranes of the transfected cells ( Figure 3A ), while 18 Syntaxin 1A-EGFP was largely confined to the endoplasmic reticulum, which is typical for cells 19 lacking neuronal binding partners that aid in its transfer to the plasma membrane. 29 Nevertheless, the 20 cells served as a good first model to test the nanobody immunostaining abilities. They revealed 21 accurately the EGFP-containing cells, and showed no signal in cells not expressing SNAP-25-EGFP or 22
Syntaxin 1A-EGFP ( Figure 3A , 3B). The nanobodies recognized specifically their intended targets, 23
whereas SNAP-25 nanobodies did not reveal Syntaxin 1A and vice versa ( Supplementary Figure 4) . 24
To complete the nanobody characterization, we also investigated the binding to their targets in 1 a western-blot (WB) assay. For this, we investigated by SDS PAGE the following: Purified 2 recombinant SNAP-25 or Syntaxin 1A produced in E. coli, lysates of HEK293 cell lines transiently 3 expressing SNAP-25 or Syntaxin 1A, lysates of total rat brain and lysates of rat primary hippocampal 4 cultures. Both nanobodies were able to bind their corresponding targets accurately ( Figure 3C, 3D ) 5 and detected no other bands on any of the lanes. Moreover, the bands detected by the nanobodies 6 match those bands detected by commonly used SNAP-25 and Syntaxin 1A antibodies (Supplementary 7 Figure 5A , 5B). We further extended this specificity study by using lysates from mouse liver, muscle, 8 heart, testes and brain. The nanobodies detected no bands in any tissues other than brain, which again 9 suggests that they are both highly specific (Supplementary Figure 5C , 5D). 
16
The scale bar represents 10 µm. Note that Syntaxin 1A accumulates in the ER-Golgi region due to an impaired 17 export caused by the lack of neuronal cofactors, as it was found in the past 30 (C & D) The following samples 18 were loaded in a denaturating SDS-PAGE and were blotted on a nitrocellulose membrane (2 µg of each purified 19 protein, and 20 µg of total protein for the cell or brain lysates): E. coli-purified full length SNAP-25 including a 20 Twin-Strep-Tag (tst; 27.8 kDa), or Syntaxin 1A fused to a SUMO domain and a Twin-Strep-Tag (44.7 kDa); 21 lysates from HEK293 cells transiently transfected with full length Syntaxin 1A-tst (HEK-Stx1A, 37.5 kDa) or 22 SNAP-25-tst (HEK-SNAP-25, 27.8 kDa); whole rat brain and rat primary hippocampal neurons (15 days in 23 vitro). Detection was performed using S25-Nb10 (C) or Stx1A-Nb6 (D) conjugated to a single Atto647N. Both 24 candidates specifically detect the bands at the expected molecular weights (displayed in the protein schematics), 1 while showing no cross-reactivity to the opposite antigen or to any other proteins present in the lysates.
3
Finally, we tested whether these nanobodies would be able to bind SNAP-25 and Syntaxin 1A 4 when engaged in a SNARE complex. We conjugated them to maleimide-functionalized agarose beads 5 and aimed to immunoprecipitate SNAP-25 or Syntaxin 1A from whole rat brain lysates 6 (Supplementary Figure 6A , 6B), and from an in vitro-formed SNARE complexes (Supplementary 7 Figure 6C , 6D). 3 Both nanobodies were able to immunoprecipitate their targets, in both experiments. 8
Moreover, they could also co-immunoprecipitate the other SNARE partner, suggesting that S25-Nb10 9 and Stx1A-Nb6 are able to bind their targets even when they are assembled in SNARE complexes. 10 11 S25-Nb10 and Stx1A-Nb6 detect more epitopes in crowded regions and penetrate more 12 efficiently into thick tissue samples. 13
After the initial characterization of the SNAP-25 and Syntaxin 1A nanobodies, we studied 14 their behavior compared to conventional antibody immunostainings. We first analyzed co-15 localizations between conventional antibodies and the corresponding nanobodies by confocal laser 16 scanning microscopy in undifferentiated PC12 cells (which have been used extensively to investigate 17 these SNAREs, as indicated in the Introduction). As expected, we observed a strong co-localization 18 between antibodies and nanobodies on PC12 cells using confocal microscopy ( Figure 4A ), especially 19 at the plasma membranes. However, both nanobodies also showed a distinctive signal in the 20 perinuclear region, where antibodies displayed a poorer detection. As membrane proteins like 21
Syntaxin 1A and SNAP-25 are expected to be present in the ER-Golgi endomembrane traffic system 31 22 located in the perinuclear area, we hypothesized that the antibodies may not be able to detect their 23 epitopes efficiently in this tightly crowded region. 24
To address this hypothesis, we again turned to COS-7 cells and to transient expression of 25 EGFP fusion chimeras of the two SNARE proteins ( Figure 4B ). We co-immunostained the cells with 26 both antibodies and nanobodies and investigated the correlation of the resulting signals with the EGFP 27 intensity. We found that both nanobodies were able to find more target epitopes in the perinuclear 28 regions, where the EGFP intensity was at its highest ( Figure 4B ). Exemplary line profiles drawn along 29 these crowded regions revealed that the nanobody signals correlated better with the EGFP signals 1 compared to the respective antibody ( Figure 4C, 4D ). An analysis of the immunostaining signal 2 intensities relative to the EGFP intensities, revealed that the nanobodies provided brighter signals, 3 especially in the highly crowded perinuclear areas ( Figure 4C, 4D ). We ruled out epitope competition 4 between the nanobodies and the antibodies to be responsible for this effect, as control experiments did 5 not indicate such an effect ( Supplementary Figure 7) . The previous experiments suggested that the antibodies can have difficulties in reaching all 1 epitopes, especially in crowded regions. This problem was also evident when staining tissue samples, 2 rat brain slices of ~35 µm thickness. The nanobodies labeled the slices throughout their entire depth, Having broadly characterized the nanobodies, we proceeded to investigate their performance 9 in primary cultured hippocampal neurons ( Figure 5 and Supplementary Figure 9A ) where both 10 nanobodies did bind their targets abundantly ( Figure 5A -5C). To exclude that signals were due to a 11 non-specific interaction between the fluorophore conjugated to the nanobodies and the neuronal 12 membranes, 32 we also immunostained neuronal cultures with a nanobody directed against GFP, 13 conjugated to the same fluorophore (Atto647N), which displayed no substantial signal under the same 14 conditions (Supplementary Figure 9B) . 15
We then analyzed the samples by two-color Stimulated Emission Depletion (STED) 16 microscopy. This revealed a different pattern of the target protein distribution between the antibodies 17 and the nanobodies. The antibodies showed a spotty pattern, concentrated mainly in synapses that 18 were revealed by immunostaining for the synaptic vesicle marker Synaptophysin. 4 The nanobodies 19 also revealed a significant signal in the surrounding areas, suggesting that substantial populations of 20 these proteins are also present outside synapses. 21
To analyze this observation, we located the center of mass of the Synaptophysin signals, taken 22 as the centers of synapses. We then performed line profiles along the axons for up to 1 µm, starting 23 from the synapse centers ( Figure 5D , 5E). The results confirmed that both nanobodies and antibodies 24 reveal more target molecules within synapses (enriched at the synapses), but the nanobodies also 25 revealed a significantly higher population of these molecules outside of synapses when compared to 26 the antibodies. Several explanations can be found to interpret this difference (see Discussion section). 27
Notably, the staining obtained with nanobodies resembles more closely the signals described in the 1 literature with GFP-tagged molecules in living neurons. 12 2 3 4 Syntaxin 1A in neurons has been that these two molecules did not seem to overlap greatly when 13 investigated by super-resolution microscopy. 11 This was also the case in our hands, with SNAP-25 and 14
Syntaxin 1A clusters appearing to only roughly correlate in axons when using antibodies ( Figure 6A ). 15
The signal correlation was much stronger when using nanobodies compared to antibodies ( Figure 6A To formally characterize these clusters, we analyzed the size and intensity for both antibody-1 and nanobody-revealed molecular arrangements from STED images. For an accurate comparison 2 between the two types of probes, the signals were expressed as fold over the signal of single antibody 3 complexes and nanobodies measured in similar STED images. The analyzed regions were separated in 4 synaptic regions, strongly immunostained for Synaptophysin and non-synaptic regions, devoid of 5 Synaptophysin signals. The analysis revealed that SNAP-25 nanobodies detected ~4-fold more 6 epitopes within synapses and ~6-fold more epitopes outside of synapses (extra-synaptic) than 7 SNAP-25 antibodies ( Figure 7A ). This suggests that SNAP-25 clusters/spots contain at least 10-80 8 molecules within synapses, and at least ~10 molecules outside of synapses (since the nanobodies do 9 not necessarily detect all of the molecules, and therefore the number of nanobodies detected per cluster 10 is only a minimal estimate for the number of molecules). For Syntaxin 1A, both antibody and 11 nanobody immunostainings revealed ~20 molecules per cluster within synapses, while the nanobody 12 revealed ~8 molecules per cluster outside of synapses, with only 1-2 revealed by the antibody (~4-fold 13 difference; Figure 7B ). 
24
This analysis reinforces the concept that the two molecules form clusters but suggests that they 1 are also prominent outside of synapses. At the same time, an analysis of the size (diameter) of the 2 clusters revealed that they averaged ~140 nm in synapses ( Figure 7C , 7D). Outside of synapses, the 3 cluster size was smaller, down to ~110 nm. Syntaxin 1A nanobodies detected larger clusters than 4 antibodies outside of synapses, presumably because the limited staining provided by antibodies 5 outside synapses was not sufficient to resolve clusters reliably in this region. Figure  21 1), which results in minimal displacement errors between the location of the fluorophore and that of 22 the target. 13, 14, 35 We therefore made efforts to generate nanobodies binding two of the major SNARE 1 proteins involved in neuronal exocytosis: SNAP-25 and Syntaxin 1A. Our objective was to obtain 2 highly specific nanobodies able to detect the endogenous proteins in a more precise manner than 3 possible with classical antibodies. The selected nanobodies displayed a high specificity and affinity to 4 their intended targets and revealed a population of SNAP-25 and Syntaxin 1A in hippocampal neurons 5 that could not be detected by conventional antibodies (Figure 5 ). Furthermore, the Syntaxin 1A 6 nanobodies provided evidence for a high, stimulation-dependent mobility for the extra-synaptic 7 population of Syntaxin 1A, which implies that these molecules presumably play a role in exocytosis 8 upon prolonged stimulation. 9 10
Selection and characterization of the nanobodies 11
During two rounds of phage-display screening, we selected for binders that should be able to 12 support stringent and prolonged washing conditions, as required to perform background-free 13 immunostainings. The monovalent nanobodies ultimately selected bind with dissociation constants 14 (KD) in the low nM range ( Supplementary Figure 2) and exhibit a very high specificity, even if 15 challenged against other conserved homologs or isoforms ( Supplementary Figure 3) . 16
Both nanobodies clearly revealed only one band in Western Blots, regardless whether the 17 SNAP-25 and Syntaxin 1A targets were produced recombinantly in bacteria or mammalian cells 18 (HEK293), or endogenously in rat brain or primary neuron lysates ( Figure 3C, 3D ). This implies that 19 they only detect single targets and that these are the intended neuronal exocytosis SNAREs, as no 20 signals could be detected in non-neuronal tissues (Supplementary Figure 5) . 21
22
The nanobodies reveal target populations that are more poorly identified by the antibodies 23
A surprising finding was that the nanobodies showed a similar behavior to antibodies in 24 immunostainings, but revealed a much larger population of intracellular (perinuclear) signals in PC12 25 cells ( Figure 3A) . Both SNAP-25 and Syntaxin 1A are present in large copy numbers in PC12 cells, 36 26 which implies that they need to be produced often and hence that they should be evident in the ER and 27
Golgi membranes of the cells. Moreover, SNAP-25 appears to be highly accumulated in the Golgi of 28 PC12 cells, because most of the activity of DHHC palmitoyl transferases, which are responsible for 1 the membrane association of SNAP-25, takes place at the cytosolic surface of the Golgi. 31 This 2 suggests that the signals revealed by the nanobodies in the perinuclear regions are not artifactual, 3 especially in view of the fact that the same behavior could be analyzed in COS-7 cells expressing 4 EGFP chimeras of the proteins (Figure 4B-4D) . 5
At the same time, this analysis demonstrated that the nanobodies can detect populations of 6 epitopes that are largely missed by the antibodies. We assumed initially that this effect would be most 7 evident in regions of high antibody staining intensity. Such regions presumably contain high levels of 8 epitopes and we argued that the antibodies may not be able to reveal all of them due to steric 9 hindrance, while the smaller nanobodies would be more efficient. The effect of steric hindrance was 10 also striking in preparations of brain slices ( Supplementary Figure 8 ) and appeared to also take place 11 in COS-7 cells overexpressing the proteins ( Figure 4B ). Hence this argument seems plausible for cases 12 in which protein crowding and/or penetration depth limit the antibodies (size 10-15 nm) more than the 13 nanobodies (size 2-3 nm). although based on numerous investigations of axonal membrane morphology and apparent protein and 17 lipid labeling in electron microscopy, we cannot argue that such regions are necessarily more crowded 18 than the synaptic ones. 37 A number of other effects probably limit the antibody ability to reveal the 19 targets in these areas. 20
First, nanobodies rely on only one binding pocket, while the antibodies are divalent. The 21 strong binding of antibodies to their targets depends on an avidity effect. Their probability to stay 22 bound to targets is higher than for monovalent probes, because when one binding pocket unbinds from 23 the target, the other is probabilistically still bound, thus strongly increasing the probability that the 24 antibodies remain bound. However, this effect has an important downside. It only takes place in areas 25
where the target is abundant, and both pockets can engage in target binding simultaneously. In areas 26
with lower target densities, as outside synapses, the avidity effect is eliminated, and the antibodies 27 have a much higher chance to be washed away. 28
Second, the nanobodies bind their epitopes stoichiometrically (one nanobody per target 1 molecule and one fluorophore per nanobody), but this relation is known to be particularly 2 heterogeneous for primary and secondary antibody detection systems. Both of the antibodies are 3 divalent and typically polyclonal secondary antibodies are used. Thus, a primary antibody may be 4 bound by multiple secondary antibodies. The avidity effect described in the previous paragraph 5 functions for polyclonal antibodies as well and thus they become stabilized in regions of high density 6 of primary antibodies. Such regions therefore may present disproportionally strong signals. Third, fixation by PFA, which is typical for most immunostainings, leaves a large fraction of 8 the targets unfixed and therefore mobile. 38, 39 Single target molecules, attached to a single antibody 9 binding pocket, can therefore diffuse until they reach areas where other target molecules are present. 10
Here the second antibody binding pocket can become bound to a second target molecule. The larger 11 molecular arrangement of two target molecules and one antibody is less mobile and is more likely to 12 remain in the area of high target density than to return to the initial low-density area. It is then 13 stabilized further by the secondary antibodies, and again contributes to disproportionally higher 14 signals within the areas where the target density was higher. 15
Finally, it may be that the antibody epitope is masked by an interacting partner or buried in a 16 different fold conformation in this extra-synaptic population of SNAP-25 and Syntaxin 1A. All these 17 effects were not measured directly in this work, and therefore their discussion is to some extent 18 speculative. 19 20
The nanobodies provided new information on the distribution of SNAP-25 and Syntaxin 1A on 21 primary hippocampal neurons. 22
The two nanobodies binding SNAP-25 and Syntaxin 1A provided a number of observations 23 that change, at least to some extent, our view on the membrane organization of these two molecules. 24
As indicated in the introduction, one of the most important features of the organization of both 25
SNAP-25 and Syntaxin 1A has been their presence in clearly distinguishable clusters, which have 26 been some of the first objects of study by super-resolution microscopy. 7,8 These clusters are detected 27 with nanobodies as expected, since GFP-tagged versions of the molecules also cluster in 28 membranes. 7,40 At the same time, some studies described membranes containing virtually only large 1 and bright clusters, which are clearly separated in membranes by cluster-free areas. 9 However, this 2 may as well be an artefact of the antibody stainings, 17 which yields a disproportional fluorescent signal 3 as discussed above. In fact, the clusters revealed by the nanobodies seem to be especially 4 heterogeneous for SNAP-25 ( Figure 7A) , with clusters varying by ~8-fold in brightness being found 5 with similar probabilities. Importantly, this is not the case for Syntaxin 1A, for which a previous study 6 emphasized the fact that inherent structural features of the molecule should limit the size of the 7 clusters that can be formed. 8 We indeed found that the size of these clusters was much more 8 homogenous than the one of SNAP-25 clusters ( Figure 7B ). 9
Two additional important effects became evident using nanobodies for stainings. First, while 10 the SNAP-25 and Syntaxin 1A clusters rarely overlapped to a significant effect in the literature, they 11 tend to do so when immunostained by nanobodies ( Figure 6 ). This confirms the observation that both 12 SNAP-25 and Syntaxin 1A are located to the same areas of membrane protein clusters or islands. 41 13 Second, the existence of a substantial extra-synaptic population of these molecules changes the current 14 perspective on their functional organization: SNAP-25 and Syntaxin 1A are also axonal, rather than 15 purely synaptic proteins. Their special features, ranging from cluster formation to peculiar membrane 16 interactions 42 or extremely rapid axonal transport 43 should therefore be discussed in this perspective. 17
For example, this implies that the SNAP-25 and Syntaxin 1A localization is unlikely to play a major 18 role in defining exocytosis, with the locations of other elements such as including SNARE-regulating 19 proteins 44 being more important in this respect. 5 20
The described differing patterns observed with nanobodies and antibodies are presumably not 21 limited to the distribution of SNAP-25 and Syntaxin 1A and thus we suggest that nanobody 22 development is also desirable for other target proteins. We conclude that small, monovalent affinity 23 tools do not only have the potential of providing higher quality super-resolution images, 13,14 but may 24 also reveal quantitative and qualitatively different features, especially by their linear signal-to-target 25 stoichiometry and by revealing target molecules that are present in low copy numbers or buried in 26 crowded regions. 27 Methods 1
Protein expression and purification 2
Full antigens and their truncated form (Figure 1 and 2 Cloning of constructs for protein expression was done according to Gibson et al. 47 Vector and 2 insert for assembly were combined in a concentration of 15 fmol each in reaction buffer and incubated 3 at 48°C for 30 minutes. 1 µl of the Gibson reaction was used to transform competent E. coli DH5α™ 4 bacteria (Thermo Fisher Scientific, Waltham, MA, USA) which were subsequently grown over night 5 on LB-agar plates supplemented with 50 µg/ml carbenicillin or kanamycin. Individual colonies were 6 grown overnight in 5 ml LB medium including the corresponding antibiotics and plasmids were 7 isolated using GeneJET™ plasmid purification kit (Thermo Fisher Scientific) for subsequent 8 sequencing to confirming the plasmid Identity (SeqLab, Göttingen, Germany). 9 10 Cell line culture 11 COS-7 cells were cultured as described before 48 in high glucose (4.5 g/l) Dulbecco's Modified 12
Eagle's Medium (DMEM) supplemented with 4% glutamine, 10% fetal calf serum (FCS) and 100 13 U/ml penicillin-streptomycin. PC12 cells were cultured in DMEM supplemented with 4 mM L-14 glutamine, 10% Horse Serum (HS), 5% FCS and 100 U/ml penicillin-streptomycin as described 15 before. 49 Cells were finally seeded on coverslips pre-cleaned with 1 M NaOH, followed by 1 M HCl 16 and finally by 100% ethanol. After thoroughly washing with sterile water, coverslips were coated with 17 0.1 mg/ml poly-L-lysine (PLL, Sigma-Aldrich). 12 to 16 hours after incubation in a humidified 18 incubator at 37 °C and 5% CO2, cells were transfected using Lipofectamine2000 ® (Thermo Fisher 19 Scientific). Typically, cells were used for immunostaining experiments the day after transfection 20 (16-20 h). 21 22
Primary neuron culture 23
Primary hippocampal neurons were cultured as described before. 50 Alternatively, neurons were 24 cultured according to Kaech and Banker 51 to obtain low density neuron cultures for 25 immunofluorescence experiments. Briefly, glia cells were prepared from cortex and seeded directly 26 into 12-well cell culture plates in Minimum Essential Medium (MEM, Sigma-Aldrich) supplemented 27 with 10% HS, 0.6% glucose, 1 mM L-glutamine and 100 U/ml penicillin-streptomycin. After four 28 days, primary neurons were seeded on glass coverslips which have been pre-cleaned with nitric acid 1 and coated with 1 mg/ml PLL before. These neuron containing coverslips were incubated onto the glia 2 cells containing wells, coverslips were placed upside down, so the cells (glia and neurons) are facing 3 each other. A few small paraffin dots on the coverslips allowed spatial separation of the two cultures. 4
The culture medium was replaced by neuronal maintenance medium as described by Kaech et al. 51 Preclinics GmbH, Potsdam). A total of six injections were given to the animal at an interval of one 11
week. Two days after the final injection, 50 ml of blood were taken and peripheral white blood cell 12 were isolated by Ficoll-gradient centrifugation. Total RNA from that preparation was extracted using 13
RNeasy purification kit (Qiagen, Hilden, Germany). Subsequently, cDNA was synthetized from 14 extracted total RNA using the SuperScript IV Reverse Transcriptase (Thermo Fisher Scientific) and 15 primers specifically aligning to the conserved IgG framework. The protocol for the amplification of 16 nanobody sequences by nested PCR was adapted from Olichon and de Marco. 52 First, the overall 17 nanobody repertoire was amplified using the universal primers GTCCTGGCTGCTCTTCTACAAGG 18 (CALL1) and GGTACGTGCTGTTGAACTGTTCC (CALL2) for ten cycles. Next, the nanobody 19 sequences were further amplified using a mixture of primers specific for IgG2 and IgG3 subtypes 20 aligning to the framework and hinge region for eight cycles in total. Forward primer sequence: 21
TCTGGTGATGCATCTGACAGCGAGGTGCAGCTGSWGGAGTCTGG 22
Reverse primer sequences: 23 GTTTTCCCCAGTGGATCCAGAACTAWTAGGGTCTTCGCTGTGGTGC and 24
GTTTTCCCCAGTGGATCCAGAAGTTTGTGGTTTTGGTGTCTTGGG. The primer overhangs 25
(highlighted in gray) were used for subsequent Gibson cloning into a phagemid vector as described 26 above. For construction of a phage display library, a modified version of the pHen2 phagemid kindly 27 provided by Dr. Frank Perez was used. 53 A FLAG-tag was included in the phagemid backbone to 28 allow detection of the expressed candidates by anti-FLAG antibodies. The ligated vectors were 1 transformed into electrocompetent TG-1 E. coli (Lucigen, Middletown, WI, USA) using 50 individual 2 electroporations to maximize library diversity. Subsequently, all transformation reactions were pooled 3 and distributed on 20 square (25 x 25 cm) LB-agar plates containing 50 µg/ml carbenicillin and 4 incubated over night at 37 °C. Dilution series of the transformations were plated to determine overall 5 library size. Next day, bacteria were scraped off the plates using LB medium and supplemented with 6 glycerol for storage at -80 °C. The overall library size was found to be ~4 x 10 7 colony forming units 7 (cfu). Briefly, an aliquot of the library was diluted into 500 ml 2xYT medium supplemented with 12 4% glucose and 50 µg/ml carbenicillin for growing at 37 °C, 120 rpm. When OD600 reached 0.5, MK-13 13 helper phages (#N0315S, New England Biolabs) or M13 K07ΔpIII hyperphages (PROGEN 14 Biotechnik, Heidelberg, Germany) were used to infect the culture. Phages were produced over night at 15 30 °C at 120 rpm in 500 ml 2xYT medium, supplemented with 50 µg/ml of both carbenicillin and 16 kanamycin. Next day, the culture was pelleted and phages were precipitated from the supernatant by 17 adding polyethyleneglycol (PEG) and NaCl to final concentrations of 5% and 500 mM, respectively . 18
The final phage titer was determined by measuring the OD260 using the empirical formula given by 19
Lee et al. 55 Antigens were immobilized to MagStrep "type3" XT beads (IBA GmbH) via a C-terminal 20
Twin-Strep-Tag fused to the protein. Phages were incubated with the immobilized antigen for 1 hour 21 at room temperature. Afterwards, a total of 10 washes with PBS were performed for at least ten 22 minutes per washing step. Retained phages were eluted using Strep-Tactin Biotin Elution Buffer (IBA 23 GmbH) for 30 minutes at room temperature. The eluted phages were subsequently used to infect 50 ml 24 of E. coli TG-1 bacteria (Lucigen) culture grown to OD600 ≈ 0.5. After incubation for 1 hour at 37 °C, 25
the culture was pelleted and resuspended in 1-2 ml of 2xYT medium. The resuspension was plated on 26 2xYT-agar plates supplemented with 50 µg/ml carbenicillin to select infected bacteria. The next day, 27 colonies were scraped off the agar plates, diluted into 2xYT medium and grown as described above for 28 a new round of biopanning. Typically, 2 panning rounds were performed for each screening procedure, 1 successively increasing the stringency of binding and washing conditions in each round. For the initial 2 panning, M13 K07ΔpIII hyperphages (PROGEN Biotechnik) were used instead of MK-13 helper 3 phages to increase the amount of initially retained nanobodies/phages. After the final biopanning 4 round, individual colonies were picked and grown in 96-well plates for a monoclonal phage-ELISA. 
Immunoblotting (dot-blots) 19
For simple validation of target binding (Supplementary Figure 1B) , 1 µg of purified antigen 20 was spotted on a nitrocellulose membrane (Amersham, Sigma-Aldrich). After blocking for 1 hour with 21 5% milk in PBS-T, the membrane was incubated with phage-containing supernatant from monoclonal 22 phage ELISA in 2.5% milk/PBS-T for 1 hour at room temperature. Bound nanobodies were detected 23 using an anti-DDDDK-tag antibody coupled to DyLight®650 (clone M2, Abcam). After washing with 24 PBS-T, membranes were imaged in an Amersham Imager 600 (GE Healthcare). For specificity and 25 epitope mapping analysis in Figure 2 , dot blots were performed as mentioned above, but detection was 26 performed using directly conjugated nanobodies to Atto647N fluorophore and read in the Amersham 27
Imager 600 (GE Healthcare). Homolog proteins of SNAP-25 and Syntaxin 1A were all purchased 28 from OriGene, Rockville, MD, USA and truncated versions were clone and produced as explained 1
above. 2 3

Tissue isolation 4
To confirm the binding specificity of the nanobody candidates, different animal tissues were 5 isolated from adult mice. Immediately after dissection, the tissues were homogenized in ice-cold PBS 6 supplemented with 1 mM EDTA and protease inhibitor cocktail (Sigma-Aldrich). The tissue was 7 homogenized with a motor-driven glass-Teflon homogenizer (Omnilab, Bremen, Germany) at 8 900 rpm, 30 strokes and snap-frozen in liquid nitrogen. Total protein concentration was determined by 9
Novagen BCA-assay (Merck). incubated on ice for 45 minutes followed by five sonication pulses of three seconds (Branson 18 Ultrasonics). After incubation on ice for another 15 minutes, cell debris was removed by 19 centrifugation for 45 minutes at 4 °C, 16,000 x g and the supernatant containing the soluble cell lysate 20 was snap-frozen in liquid nitrogen. Whole brain lysate was prepared accordingly after grinding the 21 tissue on ice with a pellet mixer (VWR, Radnor, PA, USA) in ice-cold lysis buffer. 22 23 24 25
Gel electrophoresis and Western blotting 26
Proteins were analyzed by SDS-PAGE according to Schagger and von Jagow 56 on a 10% 27 denaturating Tris/Tricine polyacrylamide gel. The Mini-Protean Tetra Cell System (BioRad, Hercules, 28 CA, USA) was used to run the gel a discontinuous buffer system at 90 volts for 120 minutes. Proteins 1 bands were visualized by staining overnight in Coomassie Brilliant Blue-250 staining solution. 2 Alternatively, polyacrylamide gels were blotted onto a nitrocellulose membrane in 50 mM Tris/HCl, 3 192 mM glycine, 20% methanol and 0.04% SDS. The membrane was blocked for 1 hour with 5% milk 4 powder in PBS-T, and subsequently incubated with the fluorescently labeled nanobody at a 5 concentration of 25 nM in 5% milk/PBS-T. After washing with PBS, membranes were imaged in an 6
Amersham Imager 600 (GE Healthcare). For Supp. Fig. 5C and 5D, loading controls were performed 7 by incubating the membrane with mouse anti pan-Actin antibody (NB600-535; Novus Biologicals) 8 pre-incubated with an excess of FluoTag-X2 anti Mouse IgG IRdye CW800 (N1202; NanoTag 9
Biotechnologies GmbH). Images were acquired using a LI-COR Odyssey Clx scanner. 
Affinity measurements 26
To determine the dissociation constant (KD) of selected nanobodies we used microscale 27 thermophoresis with a Monolith NT.115Pico Instrument (NanoTemper, Munich, Germany). 28
Fluorescently labeled nanobody was diluted into PBS containing 0.05% Tween-20, mixed with a 1 dilution series of the ligand antigen and transferred into Premium Coated Capillaries (NanoTemper) as 2 suggested by the manufacturer. KD-values were extracted from at least three independent experiments, 3 using the Affinity Analysis software from NanoTemper. 4 5 Immunostaining 6
Cells grown on PLL coated coverslips were fixed with 4% paraformaldehyde (PFA) prepared 7 in PBS pH 7.4 for 45 minutes at room temperature. Remaining unreacted PFA molecules were 8 quenched with 100 mM glycin and 100 mM NH4Cl in PBS for 20 minutes. To facilitate epitope 9 accessibility, cells were subsequently permeabilized with 0.1% Triton-X100 in PBS for ten minutes 10 under slow orbital shaking. To avoid unspecific binding of probes, cells were blocked for >1h with 11 Systems, #110302) were incubated with the cells as recommended (typically at 67 nM or 1:100 17 dilution from the stocks). Incubation was performed in PBS supplemented with 1.5% BSA for 1 hour 18 at room temperature. Alternatively, in Figure 4A the monoclonal HPC-1 antibody (Abcam, #ab3265) 19 directed against Syntaxin 1A was used at 1:100 dilution for stainings of PC12 cells. After three 20 washing steps with PBS for 10 minutes each, samples were incubated with the following fluorescently 21 labeled secondary antibodies: Goat anti guinea pig coupled to AlexaFluor488, Jackson 22
ImmunoResearch, #706-545-148; donkey anti rabbit coupled to Cy3, Dianova, #715-165-152; goat 23 anti rabbit coupled to Abberior-Star580, Abberior, #2-0012-005-8; goat anti mouse coupled to 24 Atto647N, Rockland, #610-156-121 as described before. 50,60 Alternatively, nanobodies conjugated to (NanoTag Biotechnologies GmbH). Nuclear staining for COS-7 and PC12 cells were performed using 28
Hoechst staining solution (Thermo Fisher). After three washings in PBS, coverslips were mounted in 1 Mowiöl (6 g glycerol, 6 ml deionized water, 12 ml 0.2 M Tris buffer pH 8.5, 2.4 g Mowiöl 4-88, 2
Merck Millipore) and dried over night at 4 °C. 3 4
Imaging validation of first candidates 5
Nanobodies were grouped into families based on their complementary domain region 3 6 (CDR3) described by Maas et al. 61 One representative member of each family was sub-cloned into 7
SHuffle Express E. coli (New England Biolabs) for nanobody expression as described above. The 8 crude lysate of each clone was incubated on 4% PFA fixed COS-7 cells transfected with the antigen of 9 interest fused to EGFP. After 1 h incubation and three times washing with PBS, the bound nanobody 10 was detected using an anti-DDDDK-tag antibody coupled to DyLight650 (clone M2, Abcam). A 11 colocalization of the fluorescent antibody signal with EGFP without significant background binding 12 was considered to indicate a specifically bound nanobody (Supplementary Figure 1B) . Sequences of 13 those candidates were sub-cloned into an expression vector for direct coupling to a fluorophore. 14 15
Brain slice preparation and staining 16
Brain slices were prepared on ice from adult (6-8 weeks old) Wistar rats, by perfusion with 17 PBS to remove blood, followed by incubation with 4% PFA for 60 minutes. The brains were removed 18 from the skull and incubated in 4% PFA at 4 °C overnight. On the following day, brains were 19 transferred to a solution of PBS supplemented with 30% sucrose at 4 °C until they sank to the bottom 20 of the solution, before snap-freezing and storing them at -80 °C until sectioning into 30-35 µm thick 21 slices on a Leica CM1850 cryotome. For staining, brain slices were incubated with primary antibody 22 or directly conjugated nanobody PBS containing 3% BSA overnight at 4 °C. After three washing steps 23 of ten minutes each, antibody samples were incubated with fluorescently labeled secondary antibody 24 for three hours. After washing once again three times as before, slices were mounted on glass slides in 25 thiodiethanol (TDE) by gradually increasing the concentration of TDE up to 100%. Finally, the 26 mounted slices were sealed using nail polish to avoid drying of the sample. 27 28
Pulldown and Co-Immunoprecipitation (Co-IP) 1
Nanobodies were conjugated to maleimide functionalized SulfoLink Coupling Resin (Thermo 2 Fisher Scientific) according to instructions of the manufacturer. Successful conjugation was confirmed 3 by adding 10 nmol recombinant antigen to 200 µl of the nanobody-functionalized beads (50% slurry). 4
After extensive washing with PBS, protein elution was performed by boiling the beads in 2x SDS 5 loading dye for ten minutes. Evaluation of the pulldown was done by a Coomassie SDS-PAGE 6 analysis of the input, flow-through the beads, washing and elution fractions. For pulldown of 7 SNAP-25 and Syntaxin 1A from tissue, total brain lysate was prepared as described as above. 200 µl 8 of 50% slurry Nanobody-functionalized beads were incubated with 50 µl whole brain homogenate for 9 1 hour on ice and washed three times with PBS in a self-casted spin MoBiCol column (MoBiTec, 10 Göttingen, Germany). Elutions were carried out by boiling the beads in 2x SDS loading dye for 11 10 minutes followed by SDS-PAGE analysis and Western blotting of all fractions obtained in the 12 process. Similarly, purified SNARE-complexes containing full-length SNAP-25, Syntaxin 1A and 13
Synaptobrevin 2 were prepared as before 3 and subjected to immunoprecipitation using nanobody-14 functionalized beads. The SNARE-proteins of the complex were blotted on a nitrocellulose membrane 15 and detected by monoclonal antibodies as described above. 16 17
Stimulation of primary hippocampal neurons 18
To investigate the function of the extra-synaptic populations of SNAP-25 and Syntaxin 1A, 19
14-16 days in vitro primary rat hippocampal neurons were prepared as described before. 50 Cells were 20 transferred into 37 °C prewarmed Tyrode buffer containing 124 mM NaCl, 5mM KCl, 2 mM CaCl2, 21 1 mM MgCl2, 30 mM glucose and 25 mM HEPES (pH 7.4) and stimulated for 60 seconds at 20 Hz 22 using a platinum plate stimulator (8 mm between the plates; driven from a stimulator and a stimulus 23 isolator from World Precision Instruments, Friedberg, Germany). Subsequently, neurons were directly 24 fixed using 4% PFA or kept in warm Tyrode buffer for another 5 minutes to recover before fixation. 25
Immunostainings were performed as described before using the S25-Nb10 and Stx1A-Nb6 conjugated 26
to Atto647N in combination with the synaptophysin antibody to identify the synapses. 27 28
Fluorescence imaging 1
Qualitative binding validation (Supplementary Figure 1B) was done by epifluorescence 2 imaging using an Olympus IX71 microscope equipped with 0.75 NA/60x oil objective and an 3
Olympus F-View II CCD camera (Olympus, Hamburg, Germany). Confocal image acquisition was 4 performed using a TCS SP5 STED confocal microscope (Leica Microsystems, Wetzlar, Germany) 5 with a 100x 1.4 N.A. HCX PL APO CS oil objective (Leica Microsystems). Multichannel confocal 6 images were obtained using an argon laser at 488 nm and helium/neon lasers at 594 nm and 633 nm 7 for AlexaFluor488, Cy3, and Atto647N, respectively. Fluorescent signal was detected using 8 photomultipliers. For STED microscopy, an inverse 4-channel Expert Line easy3D STED setup 9 (Abberior Instruments GmbH, Göttingen, Germany) was used. The setup was based on an Olympus 10 IX83 microscope body equipped with a plan apochromat 100x 1.4 NA oil-immersion objective 11 (Olympus). Fluorescence excitation lasers (Abberior Instruments GmbH) pulsed at 40 MHz were 12 utilized for the excitation lines 561 nm (for Abberior Star580) and 640 nm (for Atto647N). For 13 depletion of the fluorescence signal of the Star580 and Atto647N dyes, a 775 nm STED laser 14 (Abberior Instruments GmbH) pulsed at 40 MHz with an output power of ~1.250 W was used. 15
Fluorescence signal was detected using APD detectors (Abberior Instruments GmbH) in predefined 16 channels. The operation of the setup and the recording of images were performed with the Imspector 17 software, version 0.14 (Abberior Instruments GmbH). 18
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Software and image analysis 20
Gene sequences were analyzed using ApE v2.0.47 by M. Wayne Davis or CLC sequence 21 viewer v7.6.1 (Qiagen). Phylogenetic trees were created using CLC sequence viewer and molecular 22 models were created with PyMOL Molecular Graphics System v1.7.4.5. 23
Image analyses of immunofluorescence experiments and plotting of line profiles (Figure 4 ) 24 were performed using Fiji. 62 The analyses of neuronal immunostainings were performed using self-25
written Matlab routines (Mathworks Inc, Natick, MA, USA). The line scans from Figure 5 were 26 analyzed as follows: lines were drawn manually over axonal stretches containing multiple synapses. 27
The centers of the Synaptophysin (synapse) signals were determined automatically, using a center-of-28 mass routine and the lines were broken into individual scans originating in the synapse centers, 1 running in both directions for up to 500 pixels. The individual scans were then collected, overlaid and 2 averaged, for the results shown in Figure 5D , 5E and in Figure 8 . For Figure 6 , we analyzed the 3 Pearson's correlation coefficients between the fluorescence signals in the different channels, 4 exclusively within the synaptic areas which were defined by the Synaptophysin immunostainings. The 5 areas were determined by applying empirically determined thresholds in the Synaptophysin 6 immunostainings. For Figure 7A , 7B, an experienced user drew line scans manually over several 7 hundred evident protein clusters. The line scans were fitted with Lorentzian curves, and the cluster 8 intensity (summed over the entire fit) and size (full width at half maximum, FWHM of the fit) were 9 measured. These intensities were later expressed as fold over the intensity of single antibodies or 10 nanobodies. For Figure 7C , 7D we performed a similar analysis, but in an automatic fashion, relying 11 on an automated detection of the spots. This was performed by applying a band pass on the images, 12 and eliminating all signals found under an empirically-derived threshold. The remaining spots were 13 identified, and their intensity in all channels was measured; their sizes were determined by automatic 14 fits, as above. This analysis, while less precise in the identification of spots than manually-drawn 15 scans, has the advantage that it provides large numbers of spots, which enable the description of 16 smaller effects on, for example, the spot size. 17 18 Acknowledgments
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